Companies listed on Nasdaq, particularly smaller mining, life sciences, technology, and emerging growth issuers, should take note of an important change to Nasdaq’s continued listing requirements.
On July 22, 2026, the U.S. Securities and Exchange Commission (SEC) approved Nasdaq’s new continued listing rule requiring companies listed on the Nasdaq Global Select Market, Nasdaq Global Market, and Nasdaq Capital Market to maintain a minimum Market Value of Listed Securities (MVLS) of $5 million (USD).
Unlike many other Nasdaq continued listing deficiencies, companies that fail to maintain an MVLS of at least $5 million (USD) for 30 consecutive business days may face immediate suspension and delisting without first receiving the traditional compliance or cure period that is available for many other continued listing deficiencies.
For issuers accessing U.S. capital markets, the rule represents a meaningful shift in Nasdaq’s approach to continued listing standards and underscores the importance of proactive monitoring and strategic planning.
What Is Nasdaq’s New $5 Million Continued Listing Rule?
Under the new rule, Nasdaq-listed companies must maintain an MVLS of at least $5 million (ISD). MVLS is generally calculated by multiplying a company’s consolidated closing bid price by its total listed securities.
If a company’s MVLS remains below the $5 million (USD) threshold for 30 consecutive business days, Nasdaq may immediately issue a Staff Delisting Determination.
Unlike other continued listing deficiencies, such as the minimum bid price requirement, companies are not automatically entitled to a compliance period before suspension and delisting proceedings begin.
Although companies retain the right to appeal, a hearing request generally will not stay the suspension. This means trading on Nasdaq may cease while the appeal is pending. The Hearing Panel’s review is typically limited to instances in which Nasdaq made an error. In addition, the Hearings Panel has retained limited discretion to grant an exception of up to 180 days in certain circumstances, but only if the company demonstrates it can satisfy Nasdaq’s initial listing requirements, which are generally more stringent than continued listing standards.
Why Did Nasdaq Adopt the New Rule?
According to Nasdaq and the SEC, companies with extremely low market values may present increased risks of market manipulation, reduced liquidity, and diminished investor confidence.
The SEC noted that companies remaining below the $5 million (USD) threshold for extended periods frequently experienced additional continued listing deficiencies and were often ultimately delisted for other reasons. The SEC concluded that adopting a bright-line continued listing standard would help protect investors and promote fair and orderly markets.
What Does Nasdaq’s New Rule Mean for Issuers?
For many public companies, particularly those in the mining, life sciences, clean technology, and emerging technology sectors, market value can fluctuate significantly due to broader market conditions, financing activity, commodity prices, or sector-specific volatility rather than underlying business performance.
As a result, boards and management teams should not assume that compliance with other Nasdaq listing standards is sufficient. Instead, companies approaching the $5 million (USD) threshold should actively monitor their continued listing status and evaluate potential strategies before a deficiency arises. In addition, Nasdaq-listed companies should consider monitoring short positions or similar positions to keep apprised of downward pressure on the company’s stock.
Being delisted from Nasdaq may result in the listed shares being subject to the penny stock rules, resulting in a reduced willingness of broker-dealers to trade the shares.
Why Issuers Should Act Now
The absence of an automatic cure period means companies may have significantly less time to respond than they have become accustomed to under other Nasdaq continued listing requirements.
Early planning may include reviewing capital raising strategies, identifying and evaluating strategic acquisitions and other transactions that result in the issuance of additional listed shares, evaluating corporate transactions, assessing investor relations initiatives, utilizing equity incentive plans, and considering broader capital markets planning to reduce the risk of an unexpected delisting process.
For companies accessing U.S. markets, continued listing should be viewed as an ongoing strategic consideration, not simply a requirement satisfied at the time of listing.
Key Takeaways for Nasdaq Issuers
Nasdaq’s new continued listing requirement signals a more stringent approach toward companies with very low market values.
Companies listed on Nasdaq, or considering a Nasdaq listing, should ensure they understand how the rule operates and regularly monitor their market value alongside other continued listing requirements. For many companies, proactive planning today may help avoid far more significant challenges if market conditions deteriorate.